Whom and Where Are We Not Vaccinating? Coverage After the Introduction of a New Conjugate Vaccine Against Group A Meningococcus in Niger in 2010
The authors of this article, published in PLoS ONE, evaluated the first two phases of the introduction campaign of a new conjugate vaccine, MenAfriVac™, in Niger. They determined which sub-populations or areas had low levels of vaccination coverage in the regions of Tillabéri and Niamey to assist future vaccination strategies. Although overall vaccination coverage was satisfactory, the authors recommend continuing vaccination in the areas or sub-populations with low coverage and reinforcing the social mobilization of the adult population.
Author(s): Kim SH, Pezzoli L, Yacouba H, et al.
Published: 2012
Visit web page (English)
(Located at www.plosone.org)
Citation: Kim SH, Pezzoli L, Yacouba H, et al. Whom and Where Are We Not Vaccinating? Coverage After the Introduction of a New Conjugate Vaccine Against Group A Meningococcus in Niger in 2010. PLoS ONE. 2012;7(1):e29116
Resource types: Peer-reviewed journal
Diseases: Meningococcus
Topics: Introduction and service delivery; Disease burden and surveillance
Regions: Africa
